Literature DB >> 1426177

The protease from Vibrio cholerae nicks arginine at position 192 from the N-terminus of the heat-labile enterotoxin a subunit from enterotoxigenic Escherichia coli.

Y Ichinose1, T Tsuji, M Ehara, A Miyama, T Naito.   

Abstract

It was examined where a protease purified from Vibrio cholerae might nick the heat-labile enterotoxin (LT) A subunit from enterotoxigenic Escherichia coli. LT was digested by the protease and contained a fragment which had the same mobility on SDS-PAGE as that of the A1 fragment of LT digested by trypsin. The biological activity of LT by this protease was also identical to that of LT by trypsin. The amino acid sequence of the N-terminus of the A2-like fragment was Thr-Ser-Thr-Gly, which corresponded to the sequence from 193 to 196 of the A subunit. These data suggest that this protease, like trypsin, nicks arginine at position 192 from the N-terminus of the A subunit and that the biological activation of LT by this protease is similar to that by trypsin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1426177     DOI: 10.1007/BF00145394

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  20 in total

1.  Chemical characterization of the structure of cholera toxin and its natural toxoid.

Authors:  A Kurosky; D E Markel; B Touchstone; J W Peterson
Journal:  J Infect Dis       Date:  1976-03       Impact factor: 5.226

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development.

Authors:  J J Mekalanos; D J Swartz; G D Pearson; N Harford; F Groyne; M de Wilde
Journal:  Nature       Date:  1983 Dec 8-14       Impact factor: 49.962

Review 4.  Actions of cholera toxin and the prevention and treatment of cholera.

Authors:  J Holmgren
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

5.  A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera.

Authors:  J P Craig
Journal:  Nature       Date:  1965-08-07       Impact factor: 49.962

6.  Purification of Vibrio cholerae soluble hemagglutinin and development of enzyme-linked immunosorbent assays for antigen and antibody quantitations.

Authors:  A M Svennerholm; G J Strömberg; J Holmgren
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

7.  Mechanism of toxin secretion by Vibrio cholerae investigated in strains harboring plasmids that encode heat-labile enterotoxins of Escherichia coli.

Authors:  T R Hirst; J Sanchez; J B Kaper; S J Hardy; J Holmgren
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

8.  Primary structure of heat-labile enterotoxin produced by Escherichia coli pathogenic for humans.

Authors:  T Yamamoto; T Tamura; T Yokota
Journal:  J Biol Chem       Date:  1984-04-25       Impact factor: 5.157

9.  Amino acid sequence homology between cholera toxin and Escherichia coli heat-labile toxin.

Authors:  W S Dallas; S Falkow
Journal:  Nature       Date:  1980-12-04       Impact factor: 49.962

10.  Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid.

Authors:  R A Finkelstein; J J LoSpalluto
Journal:  J Exp Med       Date:  1969-07-01       Impact factor: 14.307

View more
  3 in total

1.  Cloning and genetic analysis of the Vibrio cholerae aminopeptidase gene.

Authors:  C Toma; Y Honma
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

Review 2.  Vibrio cholerae hemagglutinin(HA)/protease: An extracellular metalloprotease with multiple pathogenic activities.

Authors:  Jorge A Benitez; Anisia J Silva
Journal:  Toxicon       Date:  2016-03-04       Impact factor: 3.033

3.  A classical strain of Vibrio cholerae with diminished ability to process the proteolytically sensitive site in the A subunit of cholera toxin.

Authors:  Y Ichinose; T Tsuji; M Kato; B C Neves; K Morita; M Ehara; T Hirayama
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.